Ironwood Pharmaceuticals (IRWD) recently experienced a significant stock price drop of 5.20%, bringing its share price to $3.58. The trading volume reached 431,
Regencell Bioscience Holdings Ltd (RGC), a company specializing in traditional Chinese medicine for neurological and cognitive disorders, experienced a signific
Cumberland Pharmaceuticals (CPIX) experienced significant stock movement with a 5.40% surge. The stock is currently priced at $1.17 per share, with a trading vo
IM Cannabis Corp. (NASDAQ:IMCC) Q3 2024 Earnings Conference Call November 14, 2024 9:00 AM ETCompany ParticipantsAnna Taranko - Director of Investor and...
Revenue: $14.8 million in Q2 2024, up 11.7% from $13.2 million in Q2 2023.Gross Margin: 6% in Q2 2024, down from 26% in Q2 2023.Net Loss: $3.5 million in Q2 20
Aug 14, 2024 / 01:00PM GMTOperator Good morning, and welcome to IM Cannabis' second-quarter 2024 earnings conference call. Today's conference call is being reco
Flora Growth Corp. , a consumer-packaged goods leader and pharmaceutical distributor, reported today its financial and operating results for the three months ended March 31, 2024. 2024 has been a...
May 1, 2024 (Investorideas.com Newswire) Investorideas.com, a go-to platform for big investing ideas, reports on trading for IM Cannabis Corp. (CSE: IMCC) (NASD...
Loading... Loading...
Shares of Advanced Micro Devices, Inc. AMD fell sharply during Wednesday's session as the company reported first-quarter results and issu...
Loading... Loading...
Shares of Pinterest, Inc PINS rose sharply in today's pre-market trading following strong first-quarter earnings and upbeat second-quarte...
Shares of Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE) fell sharply during Monday’s session after the company revealed new data from the Phase 1/2 study of GTX-102 for Angelman syndrome, a genetic disorder causing developmental disabilities and nerve-related symptoms.
Shares of Medical Properties Trust, Inc. (NYSE: MPW) rose sharply in today’s pre-market trading after the company announced that it sold its majority interest in Utah Hospitals.
Shares of Byrna Technologies Inc. (NASDAQ: BYRN) rose sharply during Friday’s session after the company reported better-than-expected first-quarter revenue, and announced a CFO transition.